Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to DRAK1. The DRAK1 Recombinant Protein Antigen is derived from E. coli. The DRAK1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-047069 |
| Réf. fabricant | 18261981 |
| Gene ID (Entrez) | 9263 |
| Méthode de purification | >80% by SDS-PAGE and Coomassie blue staining |
| Nom usuel | DRAK1 Recombinant Protein Antigen |
| Contenu et stockage | −20°C, avoid freeze-thaw cycles |
| Formule | PBS and 1M Urea, pH 7.4 |
| À utiliser avec (application) | Blocking/Neutralizing, Control |
| Alias de gène | DAP kinase-related apoptosis-inducing protein kinase 1, DRAK1death-associated protein kinase-related 1, EC 2.7.11.1, serine/threonine kinase 17a, serine/threonine kinase 17a (apoptosis-inducing), serine/threonine-protein kinase 17A |
| Symbole de gène(s) | STK17A |
| Type d’étiquette | Unlabeled |
| Type de produit | Recombinant Protein Antigen |
| Quantité | 100μL |
| État réglementaire | RUO |
| Source | E.coli |
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-49813. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
